Volume 19, Issue 3, Pages (March 2017)

Slides:



Advertisements
Similar presentations
Alpha-Actinin 4 Is Associated with Cancer Cell Motility and Is a Potential Biomarker in Non–Small Cell Lung Cancer  Ming-Chuan Wang, PhD, Ying-Hua Chang,
Advertisements

Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome  Xiao Li, MD, Liyan Wan, MD, Jian Geng, MD, Chin-Lee.
Volume 355, Issue 2, Pages (December 2014)
Constitutive NF-κB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity  Honglin Zhou, Ming-Qing.
Interaction between G Protein-Coupled Receptor 143 and Tyrosinase: Implications for Understanding Ocular Albinism Type 1  Elisabetta De Filippo, Anke.
Volume 68, Issue 1, Pages e6 (October 2017)
Cell Physiol Biochem 2015;36: DOI: /
Volume 19, Issue 9, Pages (September 2017)
Volume 135, Issue 3, Pages (September 2008)
Volume 21, Issue 10, Pages (October 2013)
Volume 136, Issue 5, Pages (May 2009)
Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21
Cell Physiol Biochem 2016;39: DOI: /
90K Glycoprotein Promotes Degradation of Mutant β-Catenin Lacking the ISGylation or Phosphorylation Sites in the N-terminus  So-Yeon Park, Somy Yoon,
Volume 13, Issue 3, Pages (October 2015)
Volume 135, Issue 3, Pages (September 2008)
Volume 138, Issue 2, Pages (February 2010)
Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome  Xiao Li, MD, Liyan Wan, MD, Jian Geng, MD, Chin-Lee.
Molecular Therapy - Nucleic Acids
Alpha-Actinin 4 Is Associated with Cancer Cell Motility and Is a Potential Biomarker in Non–Small Cell Lung Cancer  Ming-Chuan Wang, PhD, Ying-Hua Chang,
Volume 68, Issue 1, Pages e6 (October 2017)
Volume 12, Issue 8, Pages (August 2015)
Yuen Yee Cheng, PhD, Michaela B
Volume 22, Issue 5, Pages (May 2012)
Volume 137, Issue 4, Pages (October 2009)
NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression
Volume 142, Issue 3, Pages e2 (March 2012)
Spleen Tyrosine Kinase Mediates EGFR Signaling to Regulate Keratinocyte Terminal Differentiation  Nan-Lin Wu, Duen-Yi Huang, Li-Fang Wang, Reiji Kannagi,
Volume 152, Issue 1, Pages (January 2019)
Volume 22, Issue 10, Pages (October 2014)
Volume 133, Issue 4, Pages (May 2008)
Molecular Therapy - Nucleic Acids
Volume 19, Issue 4, Pages (April 2017)
Volume 140, Issue 3, Pages (March 2011)
Volume 63, Issue 6, Pages (September 2016)
Volume 13, Issue 10, Pages (December 2015)
Volume 25, Issue 3, Pages (March 2017)
Wenqi Wang, Nan Li, Xu Li, My Kim Tran, Xin Han, Junjie Chen 
MicroRNA-101 Exerts Tumor-Suppressive Functions in Non-small Cell Lung Cancer through Directly Targeting Enhancer of Zeste Homolog 2  Ji-guang Zhang,
Volume 19, Issue 9, Pages (September 2017)
Volume 27, Issue 5, Pages (December 2013)
Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells  Yangling Li, Miao Xian, Bo Yang, Meidan.
Volume 21, Issue 10, Pages (October 2013)
Glucose-Induced β-Catenin Acetylation Enhances Wnt Signaling in Cancer
The Deubiquitinating Enzyme USP1 Regulates the Fanconi Anemia Pathway
Nectin-4 Mutations Causing Ectodermal Dysplasia with Syndactyly Perturb the Rac1 Pathway and the Kinetics of Adherens Junction Formation  Paola Fortugno,
Volume 115, Issue 6, Pages (December 2003)
Volume 138, Issue 4, Pages (April 2010)
Volume 2, Issue 6, Pages (December 2012)
Figure 1. LOC is highly expressed in NPC and predicts unfavorable prognosis. (A) Differential gene expression ... Figure 1. LOC is highly expressed.
Volume 15, Issue 3, Pages (March 2009)
Volume 26, Issue 6, Pages (June 2007)
Volume 23, Issue 3, Pages (April 2018)
Barbara Marinari, Costanza Ballaro, Maranke I
Volume 26, Issue 8, Pages (August 2018)
Mst1 Is an Interacting Protein that Mediates PHLPPs' Induced Apoptosis
Long Noncoding RNA BC as a Novel Therapeutic Target for Colorectal Cancer that Suppresses Metastasis by Upregulating TIMP3  Jiaxin Lin, Xin Tan,
Volume 17, Issue 12, Pages (December 2016)
Merlin/NF2-Lin28B-let-7 Is a Tumor-Suppressive Pathway that Is Cell-Density Dependent and Hippo Independent  Hiroki Hikasa, Yoshitaka Sekido, Akira Suzuki 
Volume 5, Issue 6, Pages (December 2013)
Volume 63, Issue 1, Pages (July 2016)
Volume 18, Issue 3, Pages (September 2010)
The Expression of MicroRNA-598 Inhibits Ovarian Cancer Cell Proliferation and Metastasis by Targeting URI  Feng Xing, Shuo Wang, Jianhong Zhou  Molecular.
Oliver I. Fregoso, Shipra Das, Martin Akerman, Adrian R. Krainer 
Volume 26, Issue 12, Pages e4 (March 2019)
Constitutive NF-κB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity  Honglin Zhou, Ming-Qing.
CLIC1 supports invadopodia formation in vitro and metastasis in vivo.
Fig. 6 The C9ORF72/SMCR8 complex regulates ULK1.
The interaction of PALB2 with BRCA1 is required for the assembly of PALB2, BRCA2, and RAD51 nuclear foci. The interaction of PALB2 with BRCA1 is required.
Volume 26, Issue 11, Pages e6 (March 2019)
Presentation transcript:

Volume 19, Issue 3, Pages 207-215 (March 2017) Physical and Functional Interactions between ELL2 and RB in the Suppression of Prostate Cancer Cell Proliferation, Migration, and Invasion  Xiaonan Qiu, Laura E. Pascal, Qiong Song, Yachen Zang, Junkui Ai, Katherine J. O’Malley, Joel B. Nelson, Zhou Wang  Neoplasia  Volume 19, Issue 3, Pages 207-215 (March 2017) DOI: 10.1016/j.neo.2017.01.001 Copyright © 2017 The Authors Terms and Conditions

Figure 1 Expression of ELL2 in human prostate tumor specimens. (A) qPCR analysis of ELL2 expression in laser-capture microdissected human prostate tissue specimens from normal adjacent (N) and tumor cells (C) with Gleason score ≤ 8 compared to tumor specimens with Gleason score ≥ 9. Data are presented as ratio of expression C:N. (B) Microarray analysis of ELL2 mRNA expression in normal adjacent epithelial cells (EPI ADJ PCA), PIN lesions, prostate cancer (PCA), and metastases (MET) from Tomlins et al. [22]. Data are presented as the log2 normalized median of ratios (*P < .05, **P < .01). Number of patients for each group designated in parentheses. (C) ELL2 alteration in the top 14 publicly available genomic data sets from the cBioPortal for Cancer Genomics [23,24]. Neoplasia 2017 19, 207-215DOI: (10.1016/j.neo.2017.01.001) Copyright © 2017 The Authors Terms and Conditions

Figure 2 Co-immunoprecipitation of ELL2 with RB. (A) HEK 293 cells were transfected with flag-tagged wild-type ELL2 and myc-tagged wild-type RB, and proteins were co-immunoprecipitated. (B) HEK 293 cells were transfected with flag-tagged wild-type ELL2 and myc-tagged RB deletion mutants [amino acids (aa) 1-380, 373-787, 768-928]. (C) HEK 293 cells were transfected with myc-tagged wild-type RB and flag-tagged ELL2 deletion mutants (aa 1-292, 293-531, 293-640). The reactions were immunoblotted with Flag and Myc antibodies as indicated. Each blot is representative of three repeated experiments. Neoplasia 2017 19, 207-215DOI: (10.1016/j.neo.2017.01.001) Copyright © 2017 The Authors Terms and Conditions

Figure 3 Stabilization of ELL2 by RB. (A) HEK 293 cells were transfected with 1 μg flag-tagged wild-type ELL2 and increasing amounts of myc-tagged wild-type RB. (B) HEK 293 cells were transfected with 1 μg flag-tagged wild-type ELL2 and increasing amounts of myc-tagged RB deletion mutant (aa 768-928). (C) HEK 293 cells were transfected with flag-tagged ELL2 plus wild-type RB or an myc-tagged RB deletion mutant (aa 1-380, 373-787, and 768-928). Arrow indicates unmodified myc-tagged RB protein. (D) HEK 293 cells were transfected with 1 μg GFP expression vector and indicated amount of myc-RB expression vector. (E) Effect of siRNA knockdown of ELL2 on RB protein and vice versa in C4-2 cells. The cell lysates were immunoblotted with flag and myc antibody as indicated. Each blot is representative of three repeated experiments. GAPDH served as internal loading control. Neoplasia 2017 19, 207-215DOI: (10.1016/j.neo.2017.01.001) Copyright © 2017 The Authors Terms and Conditions

Figure 4 Effect of RB and/or ELL2 knockdown on prostate cancer cell proliferation. (A) BrdU incorporation in C4-2 cells transfected with nontargeted control (siCont) siRNA, targeted to ELL2 (siELL2-1), RB (siRB-1), or concurrent ELL2 and RB knockdown. Upper panel shows BrdU-positive nuclei (red), and lower panel shows nuclear staining with SYTOX Green (green). (B) Quantification of BrdU incorporation shown as mean percentage ± SEM of BrdU-positive cells relative to the total number of cells. Results for A and B are representative of three individual experiments. (C) BrdU incorporation in LNCaP cells treated as in A. (D) Quantification of BrdU incorporation. (E) BrdU incorporation in 22RV1 cells treated as in A. (F) Quantification of BrdU incorporation (*P < .05, **P < .01, ***P < .001). Neoplasia 2017 19, 207-215DOI: (10.1016/j.neo.2017.01.001) Copyright © 2017 The Authors Terms and Conditions

Figure 5 Effect of ELL2 and/or RB knockdown on prostate cancer cell invasion. (A) Quantification of invadopodia in C4-2 cells treated with siELL2, siRB-1, and concurrent siELL2-1 + siRB-1 for 48 hours. (B) Western blot analysis of ELL2 and RB protein from C4-2 cell lysates following siRNA knockdown as in A. (C) Quantification of invadopodia in LNCaP cells treated as in A. (D) Western blot analysis for LNCaP cells as in B. Invadopodia formation was determined by phase contrast microscopy 48 hours (for C4-2) or 72 hours (for LNCaP cells) after embedding cells in a 3D Matrigel matrix. Phase contrast microscopy images were analyzed for percent invadopodia-positive cells per optical field after ELL2, RB, and concurrent ELL2 and RB silencing with siRNA compared to siControl. GAPDH served as a loading control. Results are expressed as mean ± SEM and are representative of three individual experiments. *P < .05, **P < .01, ***P < .001. Neoplasia 2017 19, 207-215DOI: (10.1016/j.neo.2017.01.001) Copyright © 2017 The Authors Terms and Conditions

Figure 6 Effect of ELL2 and/or RB knockdown on C4-2 cell migration. (A) Haptotactic Transwell migration assay in C4-2 cells following siRNA knockdown of ELL2 and RB individually or concurrently after 48 hours with 10% FBS as chemoattractant. (B) Quantification of migrated cells. Results are expressed as mean ± SEM and are representative of three individual experiments. Neoplasia 2017 19, 207-215DOI: (10.1016/j.neo.2017.01.001) Copyright © 2017 The Authors Terms and Conditions

Supplemental Figure S1 Functional assays in C4-2 cells using a second set of siRNA. (A) BrdU incorporation in C4-2 cells transfected with nontargeted control (siCont) siRNA, targeted to ELL2 (siELL2-2), RB (siRB-2), or concurrent ELL2 and RB (siDouble) knockdown. Upper panel shows BrdU-positive nuclei (red), and lower panel shows nuclear staining with SYTOX Green (green). (B) Quantification of BrdU incorporation shown as mean percentage ± SEM of BrdU-positive cells relative to the total number of cells. Results for A and B are representative of three individual experiments. (C) C4-2 cells transfected with siRNA for 48 hours as indicated were embedded in Matrigel for 48 hours before analysis of the ability to form invadopodia in different groups. (D) C4-2 cells were transfected with siRNA as indicated for 48 hours and then were placed in the top chamber. After 48 hours, the cells at the lower surface of chamber membranes (migrated) were stained and counted. Images shown are representative of different treatment groups. (E) Quantitative analysis of migrated cells. (F) Western blot shows the efficiency of knockdown on C4-2 cells. Neoplasia 2017 19, 207-215DOI: (10.1016/j.neo.2017.01.001) Copyright © 2017 The Authors Terms and Conditions

Supplemental Figure S2 Effect of siRNA knockdown of ELL2 and/or RB on the expression of Snail, E-cadherin, Vimentin, Twist, and Slug in C4-2 cells. The cell lysates were prepared 2 days after the treatment with the indicated siRNAs and then immunoblotted using indicated antibodies. GAPDH served as internal loading control. The expression of Snail and Slug exhibited some variability in different experiments, potentially due to variability in cell confluency. Neoplasia 2017 19, 207-215DOI: (10.1016/j.neo.2017.01.001) Copyright © 2017 The Authors Terms and Conditions